UK biotech using AI and aging clocks to discover single-gene factors that safely rejuvenate cells, led by its SB000 target.
Develops partial epigenetic reprogramming medicines using OSK transcription factors to restore aged cells toward a younger state.
The Audio Brief: everything you need to know about frontier tech in under 10 minutes a day.
30 sectors
One dashboard each, refreshed every day.
1,200+ companies
Funding, leadership, hiring, competitors.
Jobs board
Roles at companies LinkedIn never shows.
Frontier TV
A thousand-video wall from official channels.
Investors & exits
Who funds the frontier, and who bought what.
Frontline
The day's developments in every sector, scored.